Additional Licensee Obligations. Licensee shall notify Lonza within [***] days of when Product changes its phase of clinical trial and/or when it is first offered for commercial sale.
Appears in 3 contracts
Sources: Licence Agreement (Context Therapeutics Inc.), Licence Agreement (JATT Acquisition Corp), Licence Agreement (JATT Acquisition Corp)